Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Wesolowski

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
Journal of Oncology|June 17, 2021
A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility StudyFiladelfiya Zvinovski, Julie A Stephens, Bhuvaneswari Ramaswamy, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 22, 2023
Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patientsAbena Minta, Lucy Rose, Candice Park, et al.
NPJ Breast Cancer|June 19, 2024
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancerKai C C Johnson, Ai Ni, Dionisia Quiroga, et al.
Clinical Breast Cancer|June 20, 2025
Changes in Glucose level During Chemotherapy Treatment in Patients With Stage I-IV Breast CancerPatrick M Schnell, Mahmoud Kassem, Abdul Miah, et al.
Oncoimmunology|June 23, 2017
Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptorElizabeth L McMichael, Nicholas B Courtney, Megan C Duggan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor Positive, HER2 Negative Advanced Breast CancerRobert Wesolowski, Hope S Rugo, Jennifer M Specht, et al.
Journal of Affective Disorders|September 8, 2023
Inflamed but not impulsive: Acute inflammatory cytokine response does not impact prepotent response inhibitionAnnelise A Madison, Rebecca Andridge, Megan E Renna, et al.
Breast (Edinburgh, Scotland)|October 23, 2023
Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controlsKai Cc Johnson, Michael Grimm, Jasmine Sukumar, et al.
Brain, Behavior, and Immunity|February 21, 2026
Gut microbiota and metabolite disruption during breast cancer chemotherapy is associated with peripheral neuropathy sensory symptoms and painJeremy T Beales, Varshasnata Mohanty, Melina M Seng, et al.
Frontiers in Immunology|October 29, 2021
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With MelanomaSteven H Sun, Brooke Benner, Himanshu Savardekar, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Journal of Oncology|June 17, 2021
A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility StudyFiladelfiya Zvinovski, Julie A Stephens, Bhuvaneswari Ramaswamy, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 22, 2023
Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patientsAbena Minta, Lucy Rose, Candice Park, et al.
NPJ Breast Cancer|June 19, 2024
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancerKai C C Johnson, Ai Ni, Dionisia Quiroga, et al.
Clinical Breast Cancer|June 20, 2025
Changes in Glucose level During Chemotherapy Treatment in Patients With Stage I-IV Breast CancerPatrick M Schnell, Mahmoud Kassem, Abdul Miah, et al.
Oncoimmunology|June 23, 2017
Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptorElizabeth L McMichael, Nicholas B Courtney, Megan C Duggan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor Positive, HER2 Negative Advanced Breast CancerRobert Wesolowski, Hope S Rugo, Jennifer M Specht, et al.
Journal of Affective Disorders|September 8, 2023
Inflamed but not impulsive: Acute inflammatory cytokine response does not impact prepotent response inhibitionAnnelise A Madison, Rebecca Andridge, Megan E Renna, et al.
Breast (Edinburgh, Scotland)|October 23, 2023
Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controlsKai Cc Johnson, Michael Grimm, Jasmine Sukumar, et al.
Brain, Behavior, and Immunity|February 21, 2026
Gut microbiota and metabolite disruption during breast cancer chemotherapy is associated with peripheral neuropathy sensory symptoms and painJeremy T Beales, Varshasnata Mohanty, Melina M Seng, et al.
Frontiers in Immunology|October 29, 2021
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With MelanomaSteven H Sun, Brooke Benner, Himanshu Savardekar, et al.
Pageof 14